Found 820 clinical trials
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION
CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE
- 270 views
- 25 Mar, 2021
- 1 location
Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).
Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).
- 466 views
- 25 Mar, 2021
- 1 location
Type 2 Diabetes with CV Events & Obesity Clinical Trial
We are seeking type 2 diabetic participants who are obese/overweight and who have had a cardiovascular (CV) event (heart attack, stroke, bypass, etc.) and at risk for additional CV events for a clinical research study. This study is determining if the investigational medication is superior to insulin glargine in the …
- 0 views
- 25 May, 2023
- 1 location
Clinical Study Protocol Abbvie M11-352
Clinical Study Protocol Abbvie M11-352
- 332 views
- 25 Mar, 2021
- 1 location
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
- 555 views
- 25 Mar, 2021
- 1 location
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)
- 974 views
- 08 Nov, 2020
- 1 location
New Approaches to Dementia Heterogeneity.
This study is looking for adults who have mild cognitive impairment, Alzheimer’s, or other forms of dementia. The study is also looking for people with normal cognition, as a comparison. The study is interested in the ways that brain function changes over time with the goal of improving the ability to diagnose …
- 163 views
- 25 May, 2021
- 1 location
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
- 171 views
- 08 Dec, 2020
- 1 location
AREN03B2: Study of Kidney Tumors in Young Patients
AREN03B2: Study of Kidney Tumors in Young Patients
- 36 views
- 08 Nov, 2020
- 1 location
